16 filings
8-K
AMPE
Ampio Pharmaceuticals Inc
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
AMPE
Ampio Pharmaceuticals Inc
4 Dec 19
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
8:44am
8-K
AMPE
Ampio Pharmaceuticals Inc
29 Oct 19
Entry into a Material Definitive Agreement
12:00am
8-K
AMPE
Ampio Pharmaceuticals Inc
10 Oct 19
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
4:01pm
8-K
AMPE
Ampio Pharmaceuticals Inc
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
eq9wfq852sxbm
23 Aug 19
Departure of Directors or Certain Officers
4:02pm
8-K
477f4izvpdp3j4e q6
11 Jul 19
Changes in Registrant's Certifying Accountant
4:01pm
8-K
0tx 2lijy
10 Jul 19
Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer
4:02pm
8-K
fh0xvv 2fu
19 Jun 19
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
4:01pm
8-K
9irp07ghmh3iwl5pchym
17 Jun 19
Ampio Pharmaceuticals Announces Pricing of Public Offering
9:23am
8-K
adf27
14 Jun 19
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4:02pm
8-K
n013d2 smtvu6wy
14 Jun 19
Ampio Regulatory and Clinical Update
7:30am
8-K
fqf6n 69avjz
13 Jun 19
Departure of Directors or Certain Officers
4:30pm
8-K
19dhtqg
22 May 19
Ampio Clinical, Regulatory and Corporate Update
9:30am
8-K
uyu3lqrv
30 Apr 19
Ampio Pharmaceuticals Provides Regulatory Update
8:30am
8-K
t88zdfz
12 Apr 19
Entry into a Material Definitive Agreement
8:52pm
- Prev
- 1
- Next